Last 48 quarters of trend data · Healthcare · Medical - Instruments & Supplies
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | -249.81 | 38.86 | 3242.05 | 277.81 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 8.24 |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| P/S Ratio | 5.71 | 2.24 | 2.48 | 3.44 | 3.13 | 2.86 | 3.09 | 2.90 | 2.85 | 2.30 | 3.26 | 3.89 | 5.17 | 5.66 | 5.11 | 5.79 | 5.38 | 5.52 | 10.02 | 10.76 | 11.38 |
| — | -21.9% | -19.9% | +18.8% | +9.8% | +24.6% | -5.3% | -25.6% | -44.9% | -59.4% | -36.1% | -32.8% | -3.9% | +2.5% | -49.0% | -46.2% | -52.7% | -55.9% | -18.7% | +1.2% | +41.9% | |
| P/B Ratio | 5.82 | 2.66 | 2.85 | 3.93 | 3.53 | 3.36 | 3.36 | 3.12 | 2.84 | 2.31 | 3.11 | 3.56 | 4.39 | 4.94 | 4.20 | 4.46 | 3.98 | 4.09 | 6.46 | 6.52 | 6.56 |
| — | -20.7% | -15.4% | +25.9% | +24.2% | +45.1% | +8.0% | -12.2% | -35.3% | -53.2% | -25.9% | -20.3% | +10.4% | +20.8% | -35.0% | -31.5% | -39.4% | -55.9% | -13.6% | +9.4% | +56.1% | |
| P/FCF | 63.16 | 18.64 | — | 20.63 | 17.43 | 27.92 | — | — | 20.14 | 53.45 | — | 333.14 | — | — | — | — | — | 10372.08 | — | — | — |
| — | -33.2% | — | — | -13.5% | -47.8% | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| EV / EBITDA | 173.86 | 72.68 | 57.25 | 53.91 | 74.84 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| EV / EBIT | — | 37.75 | 191.47 | 119.95 | 142.69 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 8.21 |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 74.4% | 77.2% | 77.4% | 74.4% | 75.5% | 74.5% | 74.9% | 74.5% | 74.9% | 74.0% | 74.0% | 74.2% | 75.2% | 76.4% | 74.5% | 74.0% | 74.1% | 75.1% | 74.5% | 75.1% | 74.1% |
| — | +3.6% | +3.3% | -0.1% | +0.8% | +0.7% | +1.3% | +0.4% | -0.4% | -3.1% | -0.6% | +0.3% | +1.4% | +1.6% | -0.1% | -1.6% | +0.0% | -0.8% | -0.8% | +2.2% | +0.6% | |
| Operating Margin | -0.6% | 6.3% | 0.4% | 2.5% | 0.2% | -4.5% | -4.8% | -11.7% | -6.4% | -6.2% | -10.0% | -8.1% | -8.2% | -4.1% | -6.2% | -4.7% | -12.9% | -16.2% | -19.0% | -17.1% | -12.7% |
| — | +238.3% | +107.7% | +121.3% | +102.4% | +26.2% | +52.0% | -43.6% | +22.4% | -50.1% | -62.2% | -73.2% | +36.1% | +74.6% | +67.4% | +72.5% | -1.6% | +23.5% | +29.2% | +43.7% | -73.9% | |
| Net Margin | -2.1% | 5.8% | 0.1% | 1.2% | -0.2% | -4.5% | -5.5% | -12.5% | -6.8% | -6.9% | -12.2% | -9.2% | -9.2% | -5.1% | -6.9% | -4.7% | -14.7% | -17.6% | -20.4% | -18.8% | 137.8% |
| — | +228.2% | +101.4% | +110.0% | +97.1% | +34.0% | +55.2% | -36.3% | +26.5% | -35.8% | -76.0% | -94.0% | +37.5% | +71.1% | +66.0% | +74.8% | -110.7% | +22.9% | +28.7% | +41.6% | +1624.9% |
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -2.4% | 1.8% | 0.0% | 0.4% | -0.1% | -1.3% | -1.5% | -3.4% | -1.7% | -1.7% | -2.9% | -2.1% | -2.0% | -1.1% | -1.4% | -0.9% | -2.7% | -3.2% | -3.2% | -2.8% | 22.2% |
| — | +231.9% | +101.5% | +110.8% | +96.7% | +22.8% | +48.8% | -59.6% | +13.4% | -56.3% | -102.5% | -129.2% | +27.7% | +65.4% | +55.7% | +67.5% | -112.2% | +22.9% | +23.8% | +36.8% | +1974.1% | |
| ROA | -1.8% | 1.4% | 0.0% | 0.3% | -0.0% | -1.0% | -1.1% | -2.5% | -1.3% | -1.3% | -2.2% | -1.6% | -1.5% | -0.9% | -1.1% | -0.7% | -2.1% | -2.5% | -2.5% | -2.2% | 14.8% |
| — | +231.5% | +101.5% | +110.7% | +96.7% | +23.4% | +49.0% | -57.7% | +14.6% | -54.9% | -98.6% | -125.7% | +27.8% | +65.7% | +56.2% | +68.1% | -114.2% | -9.1% | -5.8% | +14.3% | +2208.4% | |
| ROIC | -0.6% | 1.7% | 0.1% | 0.6% | 0.0% | -1.1% | -1.1% | -2.6% | -1.3% | -1.2% | -1.8% | -1.4% | -1.3% | -0.7% | -0.9% | -0.7% | -1.7% | -2.1% | -2.1% | -1.8% | -1.5% |
| — | +259.1% | +109.0% | +124.3% | +102.9% | +9.4% | +40.6% | -85.1% | -0.6% | -77.7% | -89.4% | -118.0% | +22.4% | +67.5% | +54.7% | +63.9% | -15.0% | +29.2% | +28.5% | +37.8% | -111.1% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.18 | 0.14 | 0.15 | 0.18 | 0.16 | 0.17 | 0.17 | 0.17 | 0.17 | 0.16 | 0.17 | 0.16 | 0.16 | 0.16 | 0.17 | 0.16 | 0.17 | 0.16 | 0.16 | 0.16 | 0.15 |
| — | -17.3% | -10.5% | +7.8% | -2.9% | +2.0% | +3.1% | +3.9% | +3.2% | +0.7% | -0.1% | -2.1% | -3.3% | -1.4% | +1.6% | +4.4% | +11.4% | -15.2% | -13.5% | -12.9% | -16.5% | |
| Debt / EBITDA | 5.15 | 16.18 | 12.92 | 10.24 | 14.27 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| Current Ratio | 3.96 | 4.22 | 4.29 | 3.96 | 3.87 | 3.94 | 4.11 | 3.65 | 3.62 | 4.13 | 4.00 | 3.57 | 3.06 | 3.33 | 3.81 | 3.69 | 3.69 | 3.66 | 4.21 | 3.47 | 3.63 |
| — | +7.1% | +4.3% | +8.5% | +6.9% | -4.6% | +2.6% | +2.2% | +18.2% | +23.9% | +4.9% | -3.1% | -16.9% | -9.0% | -9.5% | +6.1% | +1.6% | +4.6% | -17.4% | -44.4% | -45.2% | |
| Quick Ratio | 2.99 | 3.19 | 3.18 | 2.99 | 2.85 | 2.83 | 2.88 | 2.62 | 2.59 | 2.93 | 2.83 | 2.66 | 2.31 | 2.56 | 3.03 | 2.90 | 2.92 | 2.93 | 3.35 | 2.78 | 2.91 |
| — | +12.8% | +10.2% | +14.2% | +10.2% | -3.3% | +2.0% | -1.4% | +12.0% | +14.5% | -6.7% | -8.2% | -20.9% | -12.7% | -9.5% | +4.2% | +0.4% | -0.5% | -25.2% | -49.7% | -50.2% | |
| Interest Coverage | -0.73 | 6.42 | 1.29 | 2.57 | 0.97 | -2.98 | -3.60 | -9.55 | -3.52 | -3.81 | -6.80 | -4.24 | -4.08 | -1.92 | -2.91 | -1.59 | -8.23 | -12.44 | -14.13 | -11.64 | 68.04 |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 48 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying ATRC stock.
AtriCure, Inc.'s current P/E is -249.8x. The average P/E over the last 3 quarters is 1186.2x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
AtriCure, Inc.'s current operating margin is -0.6%. Margins have been expanding over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking AtriCure, Inc.'s business trajectory between earnings reports.